Elekta

VIENNA – Elekta (EKTA-B.ST) is excited to announce the launch of the first phase of Elekta ONE*, our most comprehensive and advanced software portfolio for oncology departments and clinics, including radiation therapy planning, comprehensive treatment management, and delivery. It brings all Elekta software products, solutions and services under one umbrella providing all users with one unified software experience.
 
Previously, many cancer clinics have wrestled with stand-alone, closed systems, each with a different purpose. The result has been an unfavorable user experience and steep learning curve, adding pressure to an already strained resource: the clinical team. Elekta ONE aims to improve efficiency in the clinic – by as much as 50 percent**, eventually – through smarter workflows, increased automation, and by learning from every patient treated. Its workflow-driven approach and deep integration between applications allows information to flow freely, giving clinicians a seamless user experience.
 
Elekta ONE provides an intuitive, robust, and fast auto planning solution, allowing the clinical team to make faster decisions. In addition, it is the first commercially available system to feature proton therapy functionalities such as dynamic arc planning and robust linear energy transfer (LET) optimization.
 
Gustaf Salford, Elekta’s CEO, says: “Elekta ONE is an integral part of our Access 2025 strategy and our vision of a world where everyone has access to the best cancer care. Combining personalized precision and integrated informatics in a solution that enables elevated productivity, ONE addresses the major clinical and operational pressures facing oncology today and in the future.” 
 
With more automation and integration – along with easier, faster, and more secured access to data and tools – clinicians are now able to provide more personalized treatments for their patients, with less effort.
 
Elekta ONE was launched at the European Society for Radiotherapy and Oncology (ESTRO) annual meeting in Vienna. Visit booth 210 for a demonstration.
 
For more information, visit www.elekta.com/ONE
 
*Not available in all markets.
**Source: Elekta maintains data internally.

# # #
 
For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  
Time zone: CET: Central European Time
 
Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time
 
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.